CANDACE LEMKE: Open Payments
NPI 1043446776 · WARSAW, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,124 in 75 payments from 12 companies in 2025. Trend: 2023 $1,558 · 2024 $706 · 2025 $1,124
Food & beverage: $944Education: $179
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 45 | $397 |
| Teva Pharmaceuticals USA, Inc. | 4 | $203 |
| Supernus Pharmaceuticals, Inc. | 7 | $136 |
| Corium, LLC | 4 | $76 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Tris Pharma Inc | 3 | $62 |
| Alkermes, Inc. | 2 | $36 |
| Lundbeck LLC | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
Products named: Qelbree, COBENFY, Azstarys, Auvelity, CAPLYTA, Dyanavel XR, ARISTADA, UZEDY.
Industry payments across IN — which companies pay providers there.
